Hospital Universitari Germans Trias i Pujol -ko ikertzaileekin lankidetzan egindako argitalpenak (22)

2023

  1. COVID-19’s impact on care practice for alpha-1-antitrypsin deficiency patients

    BMC Health Services Research, Vol. 23, Núm. 1

  2. Hypoxic burden to guide CPAP treatment allocation in patients with obstructive sleep apnoea: a post hoc study of the ISAACC trial

    The European respiratory journal, Vol. 62, Núm. 6

  3. Obstructive sleep apnoea is related to melanoma aggressiveness through paraspeckle protein-1 upregulation

    The European respiratory journal, Vol. 61, Núm. 2

2022

  1. Effectiveness and Safety of Inhaled Antibiotics in Patients With Chronic Obstructive Pulmonary Disease. A Multicentre Observational Study

    Archivos de Bronconeumologia, Vol. 58, Núm. 1, pp. 11-21

2021

  1. Effect of a Pulmonary Embolism Diagnostic Strategy on Clinical Outcomes in Patients Hospitalized for COPD Exacerbation: A Randomized Clinical Trial

    JAMA - Journal of the American Medical Association, Vol. 326, Núm. 13, pp. 1277-1285

2020

  1. Effect of obstructive sleep apnoea and its treatment with continuous positive airway pressure on the prevalence of cardiovascular events in patients with acute coronary syndrome (ISAACC study): a randomised controlled trial

    The Lancet Respiratory Medicine, Vol. 8, Núm. 4, pp. 359-367

  2. The effect of sleep apnea on cardiovascular events in different acute coronary syndrome phenotypes

    American Journal of Respiratory and Critical Care Medicine, Vol. 202, Núm. 12, pp. 1698-1706

2019

  1. Biomarker panel in sleep apnea patients after an acute coronary event

    Clinical Biochemistry, Vol. 68, pp. 24-29

  2. The rationale, design, and methods of a randomized, controlled trial to evaluate the efficacy and safety of an active strategy for the diagnosis and treatment of acute pulmonary embolism during exacerbations of chronic obstructive pulmonary disease

    Clinical Cardiology, Vol. 42, Núm. 3, pp. 346-351

2018

  1. Lung function impairment is not associated with the severity of acute coronary syndrome but is associated with a shorter stay in the coronary care unit

    Journal of Thoracic Disease, Vol. 10, Núm. 7, pp. 4220-4229

2016

  1. Age-related risk factors for bacterial aetiology in community-acquired pneumonia

    Respirology, Vol. 21, Núm. 8, pp. 1472-1479

  2. Pneumonia presenting with organ dysfunctions: Causative microorganisms, host factors and outcome

    Journal of Infection, Vol. 73, Núm. 5, pp. 419-426

  3. Predictors of severe sepsis among patients hospitalized for community-acquired pneumonia

    PLoS ONE, Vol. 11, Núm. 1

2015

  1. Sensitivity, specificity, and positivity predictors of the pneumococcal urinary antigen test in community-acquired pneumonia

    Annals of the American Thoracic Society, Vol. 12, Núm. 10, pp. 1482-1489

2014

  1. Tobacco smoking increases the risk for death from pneumococcal pneumonia

    Chest, Vol. 146, Núm. 4, pp. 1029-1037

2012

  1. Compliance with guidelines-recommended processes in pneumonia: Impact of health status and initial signs

    PLoS ONE, Vol. 7, Núm. 5

  2. Factores asociados a la hospitalización por exacerbación de la enfermedad pulmonar obstructiva crónica

    Archivos de Bronconeumologia, Vol. 48, Núm. 3, pp. 70-76

  3. Initial management of pneumonia and sepsis: Factors associated with improved outcome

    European Respiratory Journal, Vol. 39, Núm. 1, pp. 156-162

2008

  1. Resistant pneumococcal pneumonia

    Infectious Diseases in Clinical Practice, Vol. 16, Núm. 6, pp. 368-375

2005

  1. Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease

    Archives of Internal Medicine, Vol. 165, Núm. 8, pp. 891-897